A recent study assessed whether combining a targeted therapy with an immunotherapy for ALK translocation-positive advanced non-small cell lung cancer results in more durable patient responses. READ MORE
Upregulation of a specific protein may be an indicator of radiation resistance in patients with resected non-small cell lung cancer who received radiotherapy.
A recently approved second-line therapy is reasonably effective in the treatment of advanced non-small cell lung cancer, according to a recent real-world study.
A new signature detection platform uses tumor-educated platelet RNA profiles to detect non-small-cell lung cancer.
The number of eligibility criteria and screening procedures in lung cancer clinical trials continue to rise.